Chemoinformaics analysis of Gamma-L-Glutamyl-Cysteine
| Molecular Weight | 250.276 | nRot | 7 |
| Heavy Atom Molecular Weight | 236.164 | nRig | 3 |
| Exact Molecular Weight | 250.062 | nRing | 0 |
| Solubility: LogS | -1.223 | nHRing | 0 |
| Solubility: LogP | -3.105 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 31.8051 |
| nHD | 5 | BPOL | 19.1089 |
| QED | 0.356 |
| Synth | 2.933 |
| Natural Product Likeliness | 0.607 |
| NR-PPAR-gamma | 0.025 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.018 |
| HIA | 0.056 |
| CACO-2 | -6.624 |
| MDCK | 0.002904 |
| BBB | 0.126 |
| PPB | 0.123833 |
| VDSS | 0.393 |
| FU | 0.822875 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.014 |
| CYP2c19-inh | 0.034 |
| CYP2c19-sub | 0.034 |
| CYP2c9-inh | 0.081 |
| CYP2c9-sub | 0.423 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.121 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.002 |
| CL | 3.33 |
| T12 | 0.688 |
| hERG | 0.009 |
| Ames | 0.779 |
| ROA | 0.014 |
| SkinSen | 0.226 |
| Carcinogencity | 0.038 |
| EI | 0.04 |
| Respiratory | 0.225 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.882928 |